Today on Outsourcing-Pharma.com   Results: 2007 European outsourcing awards United drug makes another services acquisition Galapagos gains grants of €5.2m Boehringer hopes cash injection will turbocharge diabetes and obesity programme US dragging its heels on biosimilars, says report

Related Industry News   Wyeth ups the ante with new proteomics method Billionaire 'raider' circles as Biogen put up for sale GSK, Synta join forces in billion dollar cancer deal Last throw of the dice for NPS Pharmaceuticals?

Breaking News on Outsourcing Pharma
Daily  Tuesday 16 October 2007		Forward to a colleague

	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Access Full Stories Results: 2007 European outsourcing awards The ten winners of the European outsourcing awards for 2007 were finally unveiled at the recently-held CPhI trade show in Milan... Read United drug makes another services acquisition United drug has purchased another services business in what is turning out to be an acquisitive year for the ambitious Irish distributor... Read Galapagos gains grants of €5.2m Galapagos and its services division BioFocus DPI have gained three new research grants totalling €5.2m... Read Boehringer hopes cash injection will turbocharge diabetes and obesity programme Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece of the action... Read US dragging its heels on biosimilars, says report The US is woefully lagging behind the EU when it comes to approving biosimilars, a new report says... Read
	All News Headlines for: October | September | August
	Related Industry News Wyeth ups the ante with new proteomics method Researchers from Wyeth Research's Biological Technologies division have described how the use of a titania-affinity enrichment step can aid in the discovery of post-translational protein modifications... Read Billionaire 'raider' circles as Biogen put up for sale Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read GSK, Synta join forces in billion dollar cancer deal GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read Last throw of the dice for NPS Pharmaceuticals? NPS pharmaceuticals has ended its collaboration with pharma giant AstraZeneca, selling the rights to the partnership for $30m (€21.2m) in order to fund development of its late-stage products... Read Weekly Comment Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development. Read Previous Headlines GSK's disdain is blatant over new rules for patent GlaxoSmithkline (GSK) has expressed its disdain for looming changes to drug patent application rules in the US and has launched a lawsuit to try and stop them coming into force next month... Read Indian firm takes over German biologics plant An Indian firm has taken over the contract biologics manufacturing business of German corporation Siegfried... Read Moss protein factories scaled up Normally, they are green, sort of spongy and found in dank nooks and crannies - but mosses have now been designed as therapeutic protein producing factories and are being implemented on a grand scale... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late involving Clinsys, Averion, PRA International and others... Read Best biopharma bosses There have been a few changes in the top ten employers according to leading journal Science's annual survey of the best companies to work for in the biotech, biopharma, pharmaceutical and related industries... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com